Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474521 - 474540 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX) other protein kinase inhibitors | RETEVMO 80MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 12.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 12.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | Pfizer,Inc. |
| USA | (L01EX03) pazopanib (adm: O) | PAZOPANIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX04) vandetanib (adm: O) | CAPRELSA 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | GenzymeCorporation |
Pages
